Dipyrone ameliorates behavioural changes induced by unpredictable chronic mild stress: gender differences Abstract Purpose: Antidepressant effects of analgesics have been investigate in both clinical and experimental studies. The purpose of this study was to investigate if the analgesic-antipyretic drug, dipyrone, also had antidepressant-like effects.
Inhibition of central cyclooxygenase system and activation of opioid and cannabinoid systems are important mechanism suggested for dipyrone, a strong analgesic and antipyretic agent [1] [2] [3] . Serotonergic-noradrenergic system, arginine-NO-cGMP pathway, neuronal potassium channels and inflammatory cytokine levels have been suggested as possible mechanisms for the analgesic action of dipyrone [4] [5] [6] . Other central effects, distinct from this analgesic effect, have been evaluated. Dipyrone has been shown to produce anticonvulsant effect in rats exposed to the audiogenic and electroshock-induced seizures [7] . Dipyrone was also found to reverse the mechanical allodynia induced by CFA, and reduce the immobility time in tail suspension test in a study that compares the depression-like behavior of analgesics and bupropion in a model of chronic inflammation-related depression in mice [8] .
Depression is a serious disorder that affects a large number of people worldwide. It has been hypothesized that functional deficiency of the brain monoaminergic transmitters is the major cause of depression. Conventional treatment of depression with antidepressants, such as monoamine re-uptake inhibitors, and cognitive behavioural therapy can be ineffective in a considerable number of patients. Moreover, antidepressant therapy has a variety of undesirable side effects such as sedation, decrease of blood pressure, increase of weight, indigestion or sexual dysfunction. These symptoms often results in patients' poor compliance, leading to a discontinuation of medication with recurrence of depressive symptoms and increased suicidal risk [9] . To investigate new, alternative, causative and/or easy available treatment strategies beyond conventional methods for prevention and treatment of depression would be an instructive study for future psychiatric care.
Mechanisms suggested for analgesic effects of dipyrone, such as change in proinflammatory cytokines levels, activation of ion channels and activity of endogenous opioid and cannabinoid systems, are involved in pathophysiology of depressive disorders also. On the other hand, depression and pain are mostly comorbid conditions -evident since pain is known to induce depression and depression to induce pain [10] . A drug, which both relieves pain and ameliorates depressive symptoms, can be an alternative treatment for patinets with comorbid depression and pain. Recently some analgesics have been recommended for comorbid cases. To this end, we studied the antidepressant-like effect of dipyrone in both genders of mice using an unpredictable chronic mild stress (UCMS) model in mice.
Materials and Methods

Animals
Swiss Albino mice of either sex weighing 20-25 g, obtained from Çukurova University Experimental Research and Application Center of Medical Sciences, were used in all experiments. They were kept in the standard laboratory conditions (12 h light-dark cycle, lights on at 08:00 am, 24±1°C) for 1 week before the onset of the experiments. Mice received food and water ad libitum. All procedures were carried out following a protocol approved by Çukurova University, Faculty of Medicine Animal Ethic Committee.
Experimental groups and drug administration
Mice were divided into non-stress (control) and UCMS-exposed (stressed) groups. Each group divided to subgroups according to gender. Control mice were housed as three mice per cage during the experiment in a separate room. Stressed mice were singly housed in their home cages. At the end of the two-week long drug-free UCMS, stressed mice were divided to three groups: I. stressed+vehicle; II. stressed+100 mg dipyrone; and, III. stressed+200 mg dipyrone (n=8 per group). Drug and vehicle were administered intraperitoneally (i.p.) each day at 13.30 pm in a volume of 0.1 ml/10 g body weight for 5 weeks. At the end of the UCMS regimen, behavioural tests were performed. Dipyrone was purchased from Sigma Chemical Company, dissolved in 0.9% saline and administered 100 or 200 mg/kg/per day. Drug doses and dosing times were chosen according to the previous studies [11] .
Unpredictable Chronic Mild Stress Model UCMS-exposed animals exhibited several neurobehavioral alterations, resembling the symptoms of chronic human depression, and are widely employed for preclinical screening of antidepressants. This model was originally described for rats [12] and mice [13] and consists of repeated mild physical and psychological stressors. In the present study, unpredictable stressors were applied according to previous studies with minor modifications. Mice were subjected several times a day for 6 weeks to one of the following stressors: exposure to a foreign object (stone); damp sawdust; sawdust changing; placement in an empty cage; placement in an empty cage with water on the bottom; switching the cages; cage tilting (45°); predator sounds for 15 min; inversion of light/dark cycle; and, lights on for a short time during the dark phase. For ethical reason, the stress procedure did not involve deprivation of food and water or immobilization. Except social stress, mice were exposed to the stressors in their own cage. To prevent habituation and provide an unpredictable feature, all stressors and/or sequences were administered at different time points every week [14, 15] .
Behavioural Tests
Coat state (CS) and body weight (BW) are important indicators of the general state in mice. It has already been reported that the UCMS procedure induces a degradation of the animal's general physical state that can be counteracted by a chronic antidepressant treatment but not by acute administration [16, 17] . CS and BW of the animals were recorded on each Monday before and during the experiments. The evaluation of the CS was carried out by assessment of eight different body parts: head (including eyes and nose); neck; dorsal coat;ventral coat; tail; forepaws; hind paws; and, genital region [16, 18] . A score of "0" for a coat in a good state or a score of "1" for a dirty coat were given for each of these areas. Dirty state is characterized by fluffy, greasy, less dense coat or piloerection. In addition, conjunctivitis and rhinitis were observed. Total scores were obtained from the sum of the score of each body parts. In all experiments, total score of the last week of the stress regimen were presented. The observers who scored the CS were unaware of the treatment condition.
Motor coordination has traditionally been assessed in mice and rats by the rota rod (RR) test, in which the animal is placed on the rotating bar at a rotating speed of 18 r.p.m. The animal must walk forwards to remain upright and not fall off for 5 minute [19] .
The splash test (ST) is validated animal model that investigates the motivational behaviour of animals. UCMS decreases grooming behaviour triggered by the ST and this phenomenon is considered to be similar to the apathy observed in depressive patients. Grooming behaviour include cleaning of the fur of the animal by licking or scratching. Grooming times were recorded by observing nose/face grooming (strokes along the snout), head washing (semicircular movements over the top of the head and behind the ears) and body grooming (body fur licking). A sucrose solution (10%) was sprayed on the neck and dorsal coat of mice. The total number of grooming was recorded for 5 min after vaporization of the sucrose solution [18] . The observer was unaware of the treatment conditions.
Forced swimming test (FST) was developed by Porsolt et al. to determine the effect of substances that have antidepressant potential. Animals were placed in a tank containing water at a temperature of 23±2°C for 6 min. A decrease of immobility was considered an antidepressant-like effect [20] . For a period of 6 min, agitation and immobility time of the animals was computed. Immobility time was measured for a period of last 4 min (the first two minutes were not recorded).
Statistical analysis
All data were expressed as means±standard error of the mean (S.E.M.). The results were analyzed using a one or two-way analysis of variance followed by the Bonferonni post hoc test and unpaired t-test corrected when appropriate. Differences between groups were considered significant when P < 0.05. 
Results
Effect of dipyrone on coat state and body weight
The coat state scores (CSS) of control, stressed and stressed+dipyrone-administered female and male mice were shown in Figure 1A (female) and 1B (male). A significant difference between the CSS of the control and the UCMS-exposed group was observed in female mice from the third week (p<0.05) and male mice from the second week. Dipyrone (100 and 200 mg/kg doses) were administered to UCMS-exposed groups on the second week. Neither 100 nor 200 mg/kg doses of dipyrone produced significant changes in CSS in the UCMS-exposed group in either the female and male mice groups. There was no statistically difference in the body weights in the female and male groups across all experimental groups from the beginning of the first week until to the end of the UCMS (data not shown).
Effect of dipyrone on locomotion in rota rod test
In the rota rod (RR) test, the stressed group showed significantly less latency to fall from the rod as compared with the control group in female mice group (89.4±14. Figure 2 ).
Effect of dipyrone on grooming behaviour in splash test
The effects of UCMS and drug treatment on the total number of grooming in splash test are shown in Figure 3 . There were no significant differences between control, stressed and dipyrone groups in female mice (166.5±12.6, 155.4±15.0, 150.4±11.0 and 152.8±13.4 sec, respectively, Figure 3 ). But male mice showed different behaviour than females: control male mice groomed significantly more than stressed males (181.5±19.25 and 122.6±12.86 sec, respectively, p<0.05). Dipyrone significantly augmented the number of grooming behaviour in stressed male mice at 100 and 200 mg/kg doses (183.4±12.9 and 216.5±24.5 sec, p<0.05, respectively, Figure 3 ).
Kiroğlu et al. in stressed female and male groups during UCMS on splash test (n=8 per group). *p<0.05 significantly different from the non-stressed control group and + p<0.05 significantly different from stressed control group in male groups using one-way ANOVA and unpaired t-test. nC = non-stressed control (vehicle) group, sC=stressed control (vehicle) group, sD 100 mg = stressed dipyrone 100 mg group, sD 200 mg = stressed dipyrone 200 mg group.
Effect of dipyrone on immobility time in the forced swimming test
Females in the stressed group showed enhanced immobility time compared with the control group in the FST (194.6±10.9 and 124.3±25.7 sec, respectively, p<0.05). Dipyrone significantly reduced the immobility time (119.4±30.0, 130.4±20.6, 194.6±10.9, respectively, p<0.05, Figure 4 ). Stress-exposed male mice showed significantly higher immobility times than those in the control group (199.8±5.2 and 124.8±10.6 sec, respectively, p<0.05) and dipyrone reduced the immobility time significantly (145.8±11.9, 143.4±10.4 and 199.8±5.2 sec, respectively, p<0.05, Figure 4 ).
Discussion
The antidepressant effects of many analgesic drugs have been observed in clinical and experimental animal studies [21] [22] [23] [24] [25] [26] [27] . Tramadol and some opioid agonists have been declared to improve depressive symptoms [22, 23] . Celecoxib and piroxicam have been shown to display antidepressant effect in human and animal studies [8, [24] [25] [26] . Acute administration of paracetamol has been shown to cause antidepressant-like effects and display synergistic effect with fluoxetine in FST and tail suspension tests without affect locomotor activity [27] . Dipyron and paracetamol have been proposed to reveal similar analgesic mechanism such as inhibition of COX enzymes in the brain, interaction with endogenous opioid and cannabinoid systems, arginine-nitric oxide-cGMP pathway, 5-HT activation [6] . Impairments in these endogenous systems also produce depressive states as indicated in clinically and experimentally studies [28] . In the present study, development of depressive-like symptoms following UCMS was evaluated via CS, RR, ST and FS tests. CS, RR and FS tests revealed that depressive behaviours occurred in both sex of UCMS-exposed mice. However, changing in grooming behaviour in the ST was seen only in UCMS-exposed male mice. Our study showed similarities [15, [29] [30] [31] and discrepancies [32] [33] with earlier studies evaluating the physical and behavioural effects of UCMS. Discrepancies may be attributed to differential strain and sex susceptibility to UCMS, to variable protocols implemented in different laboratories, to differences of environmental conditions and to experimenter bias. Yalçın showed that Balb/c mice were more susceptible to UCMS-exposure than Swiss strain mice [32] . Ibarguen-Vargas et al. subjected mice from seven different strains to a 9-week UCMS regimen and concluded that the behavioural symptoms seen in depressed mice and the efficacy of antidepressant drugs are related to strain [33] . We used Swiss mice in our experiments so discrepancies with the other studies may be related to mouse strain.
Gender is another factor that influences the behavioural effects of UCMS. Stanley et al. [34] indicated that behavioural impairments, elevations in plasma cortisol and plasma markers of oxidant stress and inflammation demonstrated in female mice in response to chronic unresolvable stresses were significantly greater than those demonstrated in male mice. Bowman et al [35] suggested that sex differences must be taken into account when investigating or describing stress and associated squeal according to their study on chronic stress effects on memory. Similar results revealing gender-related variability in vulnerability to UCMS treatment and activity of antidepressants have been demonstrated in the literature [36, 37] .
Our results indicate that male mice were more susceptible to grooming behaviour and dipyrone was effective to increase grooming in ST. Increased latency to groom and reduced total grooming time in the sucrose ST is representative of the core symptom of depression, anhedonia. These results show some similarity to earlier results indicating that the antidepressant potential of ketamine was longer lasting in males, as assessed in the ST [38] ; however, our ST results contradict other studies that report that either both sexes or only female mice are susceptible to ST. These discrepancies between various studies may be related to strain differences, as mentioned above.
In the present study, a progressive decline in CS scores was observed in all UCMS animals. This behaviour may parallel the lack of motivation to or loss of interest in performing everyday tasks, such as the maintenance of minimal personal care. Intriguingly, dipyrone did not produce any effect on this decline in CS in all UCMS-treated animals. In many studies, CS decline induced by UCMS was attributed to hippocampal degeneration. In a previous study, hippocampal irradiation completely abolished the effect of fluoxetine, which was able to reverse the CS degradation induced by UCMS non-irradiated mice [39] . From the results of rodent studies which suggest neurogenesis is necessary for mediating the salutary effects of antidepressants [40] , we may argue that dipyrone, at the doses used in the present study, was ineffective ing producing neurogenesis in hippocampal neurons. On the other hand, dipyrone produced significant improvements in locomotion and immobility time -which were impaired by UCMS in both genders of mice.
Altogether, our results indicate that the analgesic and antipyretic drug dipyrone has antidepressant-like effects in the UCMS model. This study supports a proof-of-concept concerning the use of analgesics the treatment of depression; however, more studies are needed to understand whether combined treatment with dipyrone and antidepressant drugs could be clinically beneficial in relation to the delayed therapeutic effect of classical antidepressant. Also, further studies are needed to elucidate the mechanisms of the antidepressant-like effects of dipyrone and to investigate in terms of side effects. This, in turn, could help provide better therapeutic management for patients with depression and pain comorbidity.
